American International Group, Inc. Blueprint Medicines Corp Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$73.17 - $99.79 $18,804 - $25,646	-257 Reduced 0.85%	29,971 $2.84 Million
Q4 2023 Feb 13, 2024	SELL	$43.96 - $92.84 $5,407 - $11,419	-123 Reduced 0.41%	30,228 $2.79 Million
Q3 2023 Nov 13, 2023	BUY	$46.9 - $66.0 $50,652 - $71,280	1,080 Added 3.69%	30,351 $1.52 Million
Q2 2023 Aug 04, 2023	BUY	$42.2 - $66.37 $18,188 - $28,605	431 Added 1.49%	29,271 $1.85 Million
Q1 2023 May 12, 2023	BUY	$37.97 - $50.0 $21,794 - $28,700	574 Added 2.03%	28,840 $1.3 Million
Q4 2022 Feb 10, 2023	SELL	$41.06 - $66.48 $4,229 - $6,847	-103 Reduced 0.36%	28,266 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $20,021 - $31,157	401 Added 1.43%	28,369 $1.87 Million
Q2 2022 Aug 12, 2022	SELL	$45.23 - $70.15 $48,984 - $75,972	-1,083 Reduced 3.73%	27,968 $1.41 Million
Q1 2022 May 13, 2022	SELL	$54.1 - $110.08 $110,634 - $225,113	-2,045 Reduced 6.58%	29,051 $1.86 Million
Q4 2021 Feb 11, 2022	SELL	$94.25 - $115.99 $87,746 - $107,986	-931 Reduced 2.91%	31,096 $3.33 Million
Q3 2021 Nov 12, 2021	SELL	$80.98 - $109.47 $61,625 - $83,306	-761 Reduced 2.32%	32,027 $3.29 Million
Q2 2021 Aug 13, 2021	SELL	$82.78 - $101.0 $189,897 - $231,694	-2,294 Reduced 6.54%	32,788 $2.88 Million
Q1 2021 May 07, 2021	SELL	$90.71 - $108.28 $26,396 - $31,509	-291 Reduced 0.82%	35,082 $3.41 Million
Q4 2020 Feb 12, 2021	BUY	$92.08 - $124.48 $210,126 - $284,063	2,282 Added 6.9%	35,373 $3.97 Million
Q3 2020 Nov 04, 2020	SELL	$66.45 - $92.7 $5,914 - $8,250	-89 Reduced 0.27%	33,091 $3.07 Million
Q2 2020 Aug 12, 2020	BUY	$57.09 - $79.27 $84,721 - $117,636	1,484 Added 4.68%	33,180 $2.59 Million
Q1 2020 May 04, 2020	BUY	$48.11 - $82.22 $53,738 - $91,839	1,117 Added 3.65%	31,696 $1.85 Million
Q4 2019 Feb 05, 2020	SELL	$66.73 - $82.59 $17,216 - $21,308	-258 Reduced 0.84%	30,579 $2.45 Million
Q3 2019 Nov 08, 2019	SELL	$72.9 - $101.41 $15,600 - $21,701	-214 Reduced 0.69%	30,837 $2.27 Million
Q2 2019 Aug 13, 2019	BUY	$73.54 - $97.8 $344,461 - $458,095	4,684 Added 17.76%	31,051 $2.93 Million
Q1 2019 May 06, 2019	SELL	$48.7 - $86.6 $41,638 - $74,043	-855 Reduced 3.14%	26,367 $2.11 Million
Q4 2018 Feb 13, 2019	SELL	$45.57 - $74.26 $9,569 - $15,594	-210 Reduced 0.77%	27,222 $1.47 Million
Q3 2018 Nov 09, 2018	BUY	$58.91 - $78.32 $29,160 - $38,768	495 Added 1.84%	27,432 $2.14 Million
Q2 2018 Aug 08, 2018	SELL	$60.96 - $101.18 $15,361 - $25,497	-252 Reduced 0.93%	26,937 $1.71 Million
Q1 2018 May 07, 2018	SELL	$73.28 - $102.95 $107,135 - $150,512	-1,462 Reduced 5.1%	27,189 $2.49 Million
Q4 2017 Feb 09, 2018	BUY	$62.91 - $88.32 $164,069 - $230,338	2,608 Added 10.01%	28,651 $2.16 Million
Q3 2017 Nov 09, 2017	BUY	$42.37 - $69.67 $1.1 Million - $1.81 Million	26,043	26,043 $1.81 Million

Others Institutions Holding BPMC

# of Institutions

340

Shares Held

62M

Call Options Held

987K

Put Options Held

578K

Black Rock Inc. New York, NY

6.65M
Shares

$614 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

6.54M
Shares

$604 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.87M
Shares

$543 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

3.24M
Shares

$299 Million
0.06% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.46M
Shares

$227 Million
8.22% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.52B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account